Sinopharm Group Co. Ltd. is a prominent Chinese enterprise specializing in the wholesale and retail of pharmaceuticals, medical devices, and other healthcare products. The company's diverse operations are structured into four key segments. The Pharmaceutical Distribution segment is responsible for supplying a wide array of pharmaceutical products to various healthcare entities, including hospitals, clinics, and retail pharmacies. This segment also provides comprehensive logistics and value-added services to both domestic and international manufacturers and suppliers of pharmaceutical and healthcare items. The Medical Devices segment focuses specifically on the distribution of medical equipment. Through its Retail Pharmacy segment, the company operates and franchises an extensive chain of drugstores, which totaled 10,259 locations as of December 31, 2021. The Other Business segment encompasses the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core activities, Sinopharm Group also engages in property rental and management, distributes specialized products such as Chinese herbal medicines, antibiotics, and biological products, and offers a suite of services. These include IT development, medicine, business, health, and market information consulting, international trade (import/export of goods and technology), market investigation, and convention and exhibition services. Furthermore, the company is involved in medical project investment, consulting, and technology training. To enhance its commercial capabilities and transformation, Sinopharm Group Co. Ltd. maintains a strategic partnership with I-Mab. Founded in 2003, the company is headquartered in Shanghai, China, and operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
The current price of SHTDY is $11.01 USD — it has increased by +1.72% in the past 24 hours. Watch Sinopharm Group stock price performance more closely on the chart.
What is Sinopharm Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sinopharm Group stocks are traded under the ticker SHTDY.
Is Sinopharm Group stock price growing?▼
SHTDY stock has risen by +2.85% compared to the previous week, the month change is a -2.65% fall, over the last year Sinopharm Group has showed a -8.63% decrease.
What is Sinopharm Group market cap?▼
Today Sinopharm Group has the market capitalization of 34.36B
When is the next Sinopharm Group earnings date?▼
Sinopharm Group is going to release the next earnings report on August 31, 2026.
What were Sinopharm Group earnings last quarter?▼
SHTDY earnings for the last quarter are 0.17 USD per share, whereas the estimation was 0.16 USD resulting in a +3.51% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sinopharm Group revenue for the last year?▼
Sinopharm Group revenue for the last year amounts to 160.38B USD.
What is Sinopharm Group net income for the last year?▼
SHTDY net income for the last year is 1.93B USD.
Does Sinopharm Group pay dividends?▼
Yes, SHTDY dividends are paid annual. The last dividend per share was 0.47 USD. As of today, Dividend Yield (FWD)% is 4.71%.
How many employees does Sinopharm Group have?▼
As of June 16, 2026, the company has 108,217 employees.
In which sector is Sinopharm Group located?▼
Sinopharm Group operates in the Health & Wellness sector.
When did Sinopharm Group complete a stock split?▼
Sinopharm Group has not had any recent stock splits.
Where is Sinopharm Group headquartered?▼
Sinopharm Group is headquartered in Shanghai, United States.